and an aspirin/dipyridamole combination. In the double-blind randomized PRoFESS trial, 20,332 clinically stable patients (age, ≥50) with recent ischemic strokes received either the fixed ...

The combination therapy of aspirin plus extended-release dipyridamole is superior to aspirin alone in preventing recurrent stroke in patients with TIA or minor stroke. Anticoagulant therapy is not ...

Aspirin 25mg (immediate-release), dipyridamole 200mg (extended-release); caps. Dipyridamole inhibits the uptake of adenosine into platelets, endothelial cells and erythrocytes in vitro and in vivo.

Does anti-aggregation with dipyridamole and aspirin help to prolong the primary patency of vascular access grafts? You have full access to this article via your institution. Patent vascular access ...